ME Therapeutics Holding (XCNQ:METX) Equity-to-Asset : 1.00 (As of Feb. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. ME Therapeutics Holding's Total Stockholders Equity for the quarter that ended in Feb. 2024 was C$1.36 Mil. ME Therapeutics Holding's Total Assets for the quarter that ended in Feb. 2024 was C$1.36 Mil.

The historical rank and industry rank for ME Therapeutics Holding's Equity-to-Asset or its related term are showing as below:

XCNQ:METX' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.28 Med: 0.8 Max: 1
Current: 1

During the past 2 years, the highest Equity to Asset Ratio of ME Therapeutics Holding was 1.00. The lowest was -1.28. And the median was 0.80.

XCNQ:METX's Equity-to-Asset is ranked better than
99.68% of 1562 companies
in the Biotechnology industry
Industry Median: 0.67 vs XCNQ:METX: 1.00

ME Therapeutics Holding Equity-to-Asset Historical Data

The historical data trend for ME Therapeutics Holding's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Equity-to-Asset Chart

ME Therapeutics Holding Annual Data

Trend

Aug22

Aug23

Equity-to-Asset

-1.28

0.78

ME Therapeutics Holding Quarterly Data
	Aug22	Dec22	May23	Aug23	Nov23	Feb24
Equity-to-Asset	Get a 7-Day Free Trial			0.75	0.82	0.78	0.83	1.00

Competitive Comparison of ME Therapeutics Holding's Equity-to-Asset

For the Biotechnology subindustry, ME Therapeutics Holding's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Equity-to-Asset falls into.

ME Therapeutics Holding Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

ME Therapeutics Holding's Equity to Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Equity to Asset (A: Aug. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	0.523	/	0.672
	=

ME Therapeutics Holding's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

Equity to Asset (Q: Feb. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	1.364	/	1.364
	=

ME Therapeutics Holding (XCNQ:METX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

ME Therapeutics Holding Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

Q9T:Germany

Address

177 Robson Street, Vancouver, BC, CAN, V6B 0N3

Website

https://www.metherapeutics.com

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines